Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autotaxin as a Biomarker for Breast Cancer
NCT05680311Completed
- Sponsor
- Ankara Etlik City Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Open-label trial in breast cancer (2 arms), sponsored by Ankara Etlik City Hospital. Primary endpoint: Autotaxin. Started Jan 2019; status: completed.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05680311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05680311.